Imspex has renewed its ISO 13485 certification — reinforcing our commitment to quality, compliance, and innovation in next-gen diagnostics. A strong foundation for what comes next.
Read the full press release at https://t.co/6QDYqMPXth
#MedTech#Diagnostics#ISO13485
Siloxanes in biogas may be invisible, but their impact isn’t. When combusted they form abrasive silica that damages engines and turbines. GC-IMS enables rapid, high-sensitivity siloxane monitoring, helping operators detect breakthrough early and protect infrastructure. #Siloxane
John McKinley and @amberjanejacobs will be attending BioWales in London on 18 March on behalf of Imspex. Looking forward to connecting with colleagues across life sciences and hearing about the latest Welsh innovation and investment opportunities. #BioWales
Day one at WHX Dubai: productive, busy and full of strong conversations. Finished at the Welsh Government reception at Ciel Dubai Marina — the world’s tallest hotel. Day two underway with more meetings ahead. Find us on Stand S9.A50.
Not long to go until #WHX2026 Dubai. Join Imspex on the Welsh Pavilion 📍Stand S9.A50 | 9–12 Feb.
Looking forward to great conversations, new partnerships and showcasing Welsh innovation with #TeamWales.
FlavourSpec® delivers objective VOC fingerprints for food QC.
Consistency, authenticity, off-smell detection from low-ppb down to ppt levels.
#FoodTech#FlavourScience#GCIMS
GC-IMS = fast GC + ion mobility = 2-D VOC separation, low-ppb to ppt detection.
Automated headspace. No vacuum. Minutes per run.
Full VOC fingerprints — not single-analyte sensors.
Contact us for a demo today.
#GCIMS#VOC#DeepTech
Imspex is heading to #WHXDubai, 9–12 Feb. Join us on the Welsh Government stand HS10.A50 to explore how we’re delivering Dx & Rx pathways for predictive, personalised medicine. See you in Dubai.
Great to see our CEO John McKinley representing Imspex at OBN’s BioSeed 2026 in London. Strong engagement, valuable introductions, and high-quality networking with investors and life science peers. Thanks OBN for a well-run event.
#BioSeed2026#OBN#LifeSciences @ImspexDx
John McKinley will be presenting the future of Imspex at 2:40pm today at the OBN Bioseed 2026 conference in London. Be sure to watch and introduce yourself at the networking reception!
📢 We’re hiring! Imspex Diagnostics is looking for an experienced Business Development professional in analytical chemistry/biology/instrumentation. Interested? Contact @amberjanejacobs for details: [email protected]
Days 3–4 at #MEDICA wrapped up a strong week. Clear momentum building around breath diagnostics & advanced analytics. Valuable time on the Welsh stand with @TradeWales & great innovators across Wales. Plenty to take back to IMSPEX. Danke Dusseldorf!
Day 2 at #MEDICA highlighted the pace of change across diagnostics and industry. Good discussion with @MediWales on Imspex's priorities. The Welsh stand was a great base to regroup and refocus. Day 3 now underway. @tradeandinvestwales
Day 1 at #MEDICA2025 was non-stop.
Back now and ready for Day 2.
@amberjanejacobs here with the Welsh delegation in Hall 16, Stand J03 — one of the strongest stands at the show. Big interest in what we’re doing at Imspex Diagnostics.
If you’re around, come by.
#investwales
Our Senior Research Scientist & Technical Support, Hannah Cutler, IABR Summit in Innsbruck.
Bringing together global experts in breath analysis, with discussions ranging from oncology & infectious disease to next-generation sensors & data analytics.
👉https://t.co/7uhn26IU2h
A successful day at the ‘Searchlight’ Science & Technology Capabilities Exhibition at Porton Science Park ✅
Our CEO John McKinley delivered an elevator pitch, while Amber Jacobs & Hannah Cutler met visitors on the stand. Thanks to all who stopped by!
#ScienceAndTechnology
This week, the team are engaging across Europe. Amber is in Birmingham to attend the ESS Expo, gaining insight into the latest in environmental & industrial monitoring. Hannah is in Austria at the IABR Breath Summit, with global leaders discussing the future of breath research.
Great attendance yesterday at BioWales, Level 39 Canary Wharf. CEO John McKinley outlined Imspex’s strategic vision. Honoured by visit from Rt Hon Jo Steven’s MP. Impressive showcase of Welsh Life Sciences innovation. #BioWales#Diagnostics#Wales
📢 John McKinley, CEO of Imspex, will present at BioWales London (12 March, Level39, Canary Wharf), showcasing Imspex’s diagnostics technology and strategic vision. Connect with industry experts—see you there! #BioWales#LifeSciences#MedTech
John McKinley, CEO of Imspex Diagnostics, will present at the MediWales Finance & Funding Seminar on 19th February at the Maltings, Cardiff. This is a valuable opportunity to discuss funding and growth in life sciences and health tech. #ImspexDiagnostics#Funding